Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort.
暂无分享,去创建一个
A. Haese* | F. Montorsi | D. Ankerst | S. Boorjian | A. Vickers | S. Freedland | E. Vertosick | C. Poyet | R. Leach | M. Liss | A. D. De Hoedt | J. Hernández | Lourdes Guerrios-Rivera | M. Clements
[1] Ken R. Smith,et al. Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Q. Dong,et al. First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis , 2019, BMC Cancer.
[3] E. Schaeffer,et al. Germline and Somatic Mutations in Prostate Cancer for the Clinician. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.
[4] E. Gallardo,et al. PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Lauren E. Barber,et al. Family History of Breast or Prostate Cancer and Prostate Cancer Risk , 2018, Clinical Cancer Research.
[6] M. Cooperberg,et al. A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. , 2018, European urology.
[7] Ronald C. Chen,et al. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options , 2017, The Journal of urology.
[8] Ahmet Zehir,et al. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. , 2016, The New England journal of medicine.
[9] Steven J. M. Jones,et al. The Molecular Taxonomy of Primary Prostate Cancer , 2015, Cell.
[10] Ilir Agalliu,et al. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study , 2015, Cancer.
[11] I. Thompson,et al. Incorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculator. , 2015, The Journal of urology.
[12] W. Lowrance,et al. Prostate cancer risk prediction based on complete prostate cancer family history , 2014, The Prostate.
[13] R. Hayes,et al. Do Environmental Factors Modify the Genetic Risk of Prostate Cancer? , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[14] S. Freedland,et al. Obesity and prostate cancer: weighing the evidence. , 2013, European urology.
[15] Jianfeng Xu,et al. Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1) , 2012, Journal of internal medicine.
[16] T. Nawrot,et al. An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis , 2011, PloS one.
[17] Geoffrey S. Tobias,et al. Family history of cancer and risk of pancreatic cancer: A pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan) , 2010, International journal of cancer.
[18] K. Hemminki,et al. Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. , 2010, European urology.
[19] M. Zwahlen,et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.
[20] K. Hemminki,et al. Familial association of prostate cancer with other cancers in the Swedish Family‐Cancer Database , 2005, The Prostate.
[21] J. Cerhan,et al. Family history and prostate cancer risk in a population-based cohort of Iowa men. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[22] S. Shapiro,et al. Family history and prostate cancer risk. , 1996, American journal of epidemiology.
[23] T. Sellers,et al. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. , 1994, Journal of the National Cancer Institute.